CONTEXT: Understanding factors involved in the rate of C-peptide decline is needed to tailor therapies for type 1 diabetes (T1D). OBJECTIVE: Evaluate factors associated with rate of C-peptide decline after a T1D diagnosis in young children. DESIGN: Observational study. SETTING: Academic centers. PARTICIPANTS: A total of 57 participants from the Environmental Determinants of Diabetes in the Young (TEDDY) study who were enrolled at 3 months of age and followed until T1D, and 56 age-matched children diagnosed with T1D in the community. INTERVENTION: A mixed meal tolerance test was used to measure the area under the curve (AUC) C-peptide at 1, 3, 6, 12, and 24 months postdiagnosis. OUTCOME: Factors associated with rate of C-peptide decline duri...
CONTEXT: Biomarkers that can accurately predict risk of type 1 diabetes (T1D) in genetically predisp...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
Introduction: The progression to insulin deficiency in type 1 diabetes is heterogenous. This study a...
Objective: Body weight related insulin resistance probably plays a role in progression to type 1 dia...
Objective: To identify the factors associated with residual C peptide production at least 10 years a...
Background: Recently, the growing epidemic of obesity is mirrored in the increasing incidence rate o...
Objective: C-peptide is conventionally used in assessing pancreatic function in patients with diabet...
Objectives C-peptide (CP) loss in type 1 diabetes (T1D) is highly variable, and factors influencing ...
This study was done to characterize the natural course of C-peptide levels in patients with type 1 d...
Objective: The aim of this study is to identify risk factors for the loss of measurable plasma C-pep...
Context and objective: Ghrelin secretion is altered at the onset and after the start of insulin ther...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
CONTEXT: Biomarkers that can accurately predict risk of type 1 diabetes (T1D) in genetically predisp...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
Aims/hypothesis: We studied the decline of C-peptide during the first year after diagnosis of Type 1...
Introduction: The progression to insulin deficiency in type 1 diabetes is heterogenous. This study a...
Objective: Body weight related insulin resistance probably plays a role in progression to type 1 dia...
Objective: To identify the factors associated with residual C peptide production at least 10 years a...
Background: Recently, the growing epidemic of obesity is mirrored in the increasing incidence rate o...
Objective: C-peptide is conventionally used in assessing pancreatic function in patients with diabet...
Objectives C-peptide (CP) loss in type 1 diabetes (T1D) is highly variable, and factors influencing ...
This study was done to characterize the natural course of C-peptide levels in patients with type 1 d...
Objective: The aim of this study is to identify risk factors for the loss of measurable plasma C-pep...
Context and objective: Ghrelin secretion is altered at the onset and after the start of insulin ther...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
CONTEXT: Biomarkers that can accurately predict risk of type 1 diabetes (T1D) in genetically predisp...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...
OBJECTIVE: To identify predictors of residual beta-cell function and glycemic control during the fir...